These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

642 related items for PubMed ID: 15919466

  • 1. Steroid avoidance immunosuppression in low-risk kidney transplant recipients.
    Heilman RL, Mazur MJ, Reddy KS, Moss A, Post D, Mulligan D.
    Transplant Proc; 2005 May; 37(4):1785-8. PubMed ID: 15919466
    [Abstract] [Full Text] [Related]

  • 2. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
    Heilman RL, Chakkera HA, Reddy KS, Colby TV, Moss AA, Williams JW, Mazur MJ, Petrides S, Mulligan DC.
    Clin Transplant; 2008 May; 22(3):309-15. PubMed ID: 18482051
    [Abstract] [Full Text] [Related]

  • 3. A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience.
    Alloway RR, Hanaway MJ, Trofe J, Boardman R, Rogers CC, Hanaway MJ, Buell JF, Munda R, Alexander JW, Thomas MJ, Roy-Chaudhury P, Cardi M, Woodle ES.
    Transplant Proc; 2005 Mar; 37(2):802-3. PubMed ID: 15848537
    [Abstract] [Full Text] [Related]

  • 4. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration.
    Andrés A, Budde K, Clavien PA, Becker T, Kessler M, Pisarski P, Fornara P, Burmeister D, Hené RJ, Cassuto-Viguier E, SENIOR Study Team.
    Transplantation; 2009 Nov 15; 88(9):1101-8. PubMed ID: 19898206
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathologic evaluation of short-term outcome after early corticosteroid discontinuation in kidney transplantation.
    Miura M, Ogawa Y, Kubota KC, Harada H, Shimoda N, Seki T, Hirano T, Nonomura K.
    Clin Transplant; 2009 Aug 15; 23 Suppl 20():10-6. PubMed ID: 19594589
    [Abstract] [Full Text] [Related]

  • 7. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus.
    Rodrigo E, de Cos MA, Fernández-Fresnedo G, Sánchez B, Ruiz JC, Piñera C, Palomar R, Cotorruelo JG, Gómez-Alamillo C, de Castro SS, de Francisco AL, Arias M.
    Transplant Proc; 2005 Nov 15; 37(9):3819-20. PubMed ID: 16386549
    [Abstract] [Full Text] [Related]

  • 8. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R, Cinti P, Lai Q, Poli L, Berloco PB.
    Transpl Immunol; 2008 Nov 15; 20(1-2):3-5. PubMed ID: 18773959
    [Abstract] [Full Text] [Related]

  • 9. Corticosteroid-free immunosuppression in pediatric liver transplantation: safety and efficacy after a short-term follow-up.
    Cintorino D, Riva S, Spada M, Minervini M, Sonzogni A, Foglieni CS, Gruttadauria S, Verzaro R, Henderson K, Aricò M, Gridelli B.
    Transplant Proc; 2006 May 15; 38(4):1099-100. PubMed ID: 16757276
    [Abstract] [Full Text] [Related]

  • 10. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 11. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT, Tubbs RS, Shoja MM, Ghafari A, Noshad H, Ardalan MR.
    Transplant Proc; 2008 Jan 27; 40(1):137-9. PubMed ID: 18261569
    [Abstract] [Full Text] [Related]

  • 12. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ, Mazariegos GV, Sindhi R, Abu-Elmagd KM, Reyes J.
    J Pediatr Surg; 2005 Jan 27; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [Abstract] [Full Text] [Related]

  • 13. Effect of race on the occurrence of posttransplant diabetes in kidney transplant recipients treated with early steroid discontinuation.
    Walczak D, Calvert D, Oberholzer J, Testa G, Sankary H, Benedetti E.
    Transplant Proc; 2005 Mar 27; 37(2):819-21. PubMed ID: 15848543
    [Abstract] [Full Text] [Related]

  • 14. No-load sirolimus with tacrolimus and steroids is safe and effective in renal transplantation.
    Tellis V, Schechner R, Mallis M, Rosegreen S, Glicklich D, Moore N, Greenstein S.
    Transplant Proc; 2005 Mar 27; 37(2):906-8. PubMed ID: 15848571
    [Abstract] [Full Text] [Related]

  • 15. Posttransplant diabetes mellitus: incidence and risk factors.
    Mazali FC, Lalli CA, Alves-Filho G, Mazzali M.
    Transplant Proc; 2008 Apr 27; 40(3):764-6. PubMed ID: 18455010
    [Abstract] [Full Text] [Related]

  • 16. Incidence of glucose metabolic abnormalities in Indian living renal allograft recipients on tacrolimus-based triple drug immunosuppression.
    Sharma A, Minz M, Singh S.
    Transplant Proc; 2008 Sep 27; 40(7):2414-5. PubMed ID: 18790252
    [Abstract] [Full Text] [Related]

  • 17. A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen.
    Han DJ, Park JB, Kim YS, Kim SJ, Ha J, Kim HC, Kim SJ, Moon IS, Yang CW.
    Transplant Proc; 2012 Jan 27; 44(1):115-7. PubMed ID: 22310592
    [Abstract] [Full Text] [Related]

  • 18. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D.
    J Nephrol; 2004 Jan 27; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [Abstract] [Full Text] [Related]

  • 19. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ, West-Thielke PM, Herren HL, Bareato U, Ommert T, Vidanovic V, Campbell-Lee SA, Tzvetanov IG, Sankary HN, Kaplan B, Benedetti E, Oberholzer J.
    Transplantation; 2009 Jan 27; 87(2):268-73. PubMed ID: 19155983
    [Abstract] [Full Text] [Related]

  • 20. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
    Stevens RB, Mercer DF, Grant WJ, Freifeld AG, Lane JT, Groggel GC, Rigley TH, Nielsen KJ, Henning ME, Skorupa JY, Skorupa AJ, Christensen KA, Sandoz JP, Kellogg AM, Langnas AN, Wrenshall LE.
    Transplantation; 2008 May 27; 85(10):1391-9. PubMed ID: 18497677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.